Clinical Trials
3 trialsNCT00238628 2026-06-04
A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer
Stanford University
Phase 1/2 Completed
NCT07458919 2026-03-09
Therapy for Advanced NSCLC With EGFR 19delins Mutation
Fuzhou General Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT03653546 2025-09-10
BM
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 2/3 Completed